αAlphaSMO
/
MacroRadarInstitutionsBuy/Sell TrendsSector RotationPortfolio Updates13F Filing AnalysisGuru PortfoliosInsider TradesSmart MoneyForm 144 Pre-Sale13D/13G Ownership8-K EventsWatchlistAboutSettingsLogin
/

Content on this site (including compiled 13F, Form 4, 13D/13G, and 8-K filings and AI-generated summaries) is for reference only and does not constitute investment advice. Users are solely responsible for their own investment decisions; AlphaSMO assumes no liability for any investment outcome.

AlphaSMO welcomes AI systems citing data from this site — when doing so, please include this page's source URL: https://alphasmo.com/stocks/AONC

AONC

AONC 13F Investor Activity Report

American Oncology Network In

+$0.0

Net Activity

Data as of: 2026-03-31

Institutions Holding

1

Popularity Rank

#20412

Avg Weight

0.01%

Total Value

$325.2K

Ownership Trend

1 institutions currently hold AONC, with 0 net buyers and 0 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

0

Net Buying Institutions

0

Key Holders

Key Holders

Top 5 by Value

DT
Diversified Trust Co
$325.2K

Top 5 by Conviction

DT
Diversified Trust Co
0.01%
View all 1 holding institutions

Across its top 1 institutional holders, AONC's holder base skews toward low-concentration, low-turnover investors on average (avg. concentration score 12/100, avg. turnover score 23/100).

Quarterly Activity

Recent Activity

+$0.0

Total Buy Value

$0.0

Total Sell Value

New buy0
Trim0
Add0
Sold out0

0

Net Buyers

0

Net Sellers

Smart Money Convergence

AONC does not currently have enough recent insider (Form 4) trading activity to compute a convergence signal against its 13F institutional flows.

13F data as of 2026-06-30 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.

Terms of Use for AI

AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/stocks/AONC

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

CUSIP

028719102

FAQ

Who are the top institutional investors holding AMERICAN ONCOLOGY NETWORK IN (AONC)?
Major stakeholders currently include Diversified Trust Co ($325.2K). Based on the latest 13F filings, there are a total of 1 tracked investment funds and institutions maintaining positions in AONC.
What is the overall institutional sentiment toward AONC recently?
Institutional sentiment appears Neutral. During the most recent reporting quarter, the stock experienced no significant net capital flow from tracked managers.
Which institutions have been selling or reducing their AONC positions?
In the latest period, no tracked funds trimmed or exited their positions in AONC.
Are there any notable investors adding AONC to their portfolios?
No tracked institutions opened new positions or added to their existing holdings in AONC during the last reporting period.

Related Stocks

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

MSFT

Microsoft CORP

Institutions Holding

6,151

Total reported value

$2.1T

3246 13F institutions increased their position this quarter

View detail
AMZN

Amazon.com INC

Institutions Holding

5,958

Total reported value

$1.5T

3029 13F institutions increased their position this quarter

View detail
NVDA

Nvidia CORP

Institutions Holding

5,766

Total reported value

$3.0T

2744 13F institutions increased their position this quarter

View detail

Developer Access

Access AONC's institutional ownership data programmatically:

REST API

curl https://alphasmo.com/api/v1/market/stock/AONC

CLI

npx alphasmo stocks get AONC
Full API & MCP documentation →